Physician profile
Elizabeth A Snoderly
NPI 1982652749
$5,315.23
in general payments reported to CMS, 2019-2025
32 companies · $950 in 2025
The $950 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $205 · 2021: $587 · 2022: $2,147 · 2023: $325 · 2024: $663 · 2025: $950.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,937.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,129.58 | 2021-2025 | Inceptiv, Intellis Adaptivestim |
| Boston Scientific Corporation | $1,263.68 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Superion Indirect Decompression System |
| Collegium Pharmaceutical, INC. | $240.80 | 2019-2025 | Xtampza, Belbuca |
| Si-Bone, INC. | $224.50 | 2022-2023 | |
| Vertos Medical, INC. | $171.57 | 2021-2022 | |
| Forte Bio-Pharma LLC | $170.62 | 2020-2025 | Prolate, Tanlor, Nalocet |
| Saluda Medical Americas, INC. | $139.32 | 2025 | Evoke |
| Biodelivery Sciences International, INC. | $139.23 | 2019-2021 | |
| Dexcom, INC. | $88.08 | 2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Spr Therapeutics, INC | $77.00 | 2024 | Sprint Pns System |
| Vertex Pharmaceuticals Incorporated | $71.30 | 2024-2025 | |
| Scilex Pharmaceuticals INC. | $69.10 | 2019-2021 | |
| Abbvie INC. | $67.02 | 2024-2025 | |
| Orthogenrx INC. | $54.51 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $42.03 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $40.36 | 2022 | |
| Globus Medical, INC. | $36.52 | 2025 | Senza |
| Curonix LLC | $34.76 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nevro Corp. | $32.40 | 2019 | |
| Tonix Medicines, INC. | $26.96 | 2025 | Tonmya |
| Medtronic USA, INC. | $24.27 | 2019-2020 | |
| Nalu Medical, INC. | $21.82 | 2023 | Nalu Neurostimulation System |
| Protega Pharmaceutials INC | $21.14 | 2023 | Roxybond |
| Spinal Simplicity, LLC | $17.25 | 2022 | |
| Allergan, INC. | $15.94 | 2020 | |
| Pernix Therapeutics Holdings, INC. | $15.58 | 2019 | |
| Abbott Laboratories | $15.15 | 2024 | Eterna |
| Arbor Pharmaceuticals, INC. | $14.51 | 2021 | |
| Pfizer INC. | $13.33 | 2021 | |
| Sentynl Therapeutics, INC. | $12.63 | 2019 | |
| Glaxosmithkline, LLC. | $12.21 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Snoderly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.